MedShape this week announced that it has appointed Greg Berlet as chief medical officer.
Berlet will be responsible for new clinically-focused initiatives to advance the knowledge and use of active, adaptive healing approaches for orthopedic surgeons to improve patient outcomes.
“MedShape is changing the paradigm for how fusion is addressed in foot & ankle orthopedics with the company’s products demonstrating clinical success across various challenging patient populations,” Berlet said in a news release. “I look forward to working with the MedShape team to deliver novel dynamic fusion solutions to more patients and to develop a better understanding on how dynamic fixation impacts the healing process.”
Berlet has more than 22 years of experience as a foot and ankle fellowship-trained orthopedic surgeon and is a founding partner of the Orthopedic Foot and Ankle Center in Columbus, Ohio.
“We are pleased to formally welcome Dr. Berlet to the MedShape team,” CEO Kurt Jacobus said. “His passion for research and innovation coupled with his astute understanding of the dynamic interactions of biology and technology in bone healing directly align with the company’s own mission.”
